Literature DB >> 11929764

Extensive in vivo self-renewal, long-term reconstitution capacity, and hematopoietic multipotency of Pax5-deficient precursor B-cell clones.

Christoph Schaniel1, Marie Gottar, Eddy Roosnek, Fritz Melchers, Antonius G Rolink.   

Abstract

Self-renewal, pluripotency, and long-term reconstitution are defining characteristics of single hematopoietic stem cells. Pax5(-/-) precursor B cells apparently possess similar characteristics. Here, using serial transplantations, with in vitro recloning and growth of the bone marrow-homed donor cells occurring after all transplantations, we analyzed the extent of self-renewal and hematopoietic multipotency of Pax5(-/-) precursor B-cell clones. Moreover, telomere length and telomerase activity in these clones was analyzed at various time points. Thus far, 5 successive transplantations have been performed. Clones transplanted for the fifth time, which have proliferated for more than 150 cell divisions in vitro, still repopulate the bone marrow with precursor B cells and reconstitute these recipients with lymphoid and myeloid cells. During this extensive proliferation, Pax5(-/-) precursor B cells shorten their telomeres at 70 to 90 base pairs per division. Their telomerase activity remains at 3% of that of HEK293 cancer cells during all serial in vivo transplantations/in vitro expansions. Together, these data show that Pax5(-/-) precursor B-cell clones possess extensive in vivo self-renewal capacity, long-term reconstitution capacity, and hematopoietic multipotency, with their telomeres shortening at the normal rate.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11929764     DOI: 10.1182/blood.v99.8.2760

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  7 in total

1.  Epstein-Barr virus LMP2A interferes with global transcription factor regulation when expressed during B-lymphocyte development.

Authors:  Toni Portis; Richard Longnecker
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

2.  Myeloid lineage switch of Pax5 mutant but not wild-type B cell progenitors by C/EBPalpha and GATA factors.

Authors:  Barry Heavey; Christoforos Charalambous; Cesar Cobaleda; Meinrad Busslinger
Journal:  EMBO J       Date:  2003-08-01       Impact factor: 11.598

3.  A congenital mutation of the novel gene LRRC8 causes agammaglobulinemia in humans.

Authors:  Akihisa Sawada; Yoshihiro Takihara; Ji Yoo Kim; Yoshiko Matsuda-Hashii; Sadao Tokimasa; Hiroyuki Fujisaki; Keiko Kubota; Hiroko Endo; Takashi Onodera; Hideaki Ohta; Keiichi Ozono; Junichi Hara
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

4.  The diabetes-linked transcription factor PAX4 promotes {beta}-cell proliferation and survival in rat and human islets.

Authors:  Thierry Brun; Isobel Franklin; Luc St-Onge; Anna Biason-Lauber; Eugene J Schoenle; Claes B Wollheim; Benoit R Gauthier
Journal:  J Cell Biol       Date:  2004-12-13       Impact factor: 10.539

Review 5.  Understanding and Modulating Immunity With Cell Reprogramming.

Authors:  Cristiana F Pires; Fábio F Rosa; Ilia Kurochkin; Carlos-Filipe Pereira
Journal:  Front Immunol       Date:  2019-12-11       Impact factor: 7.561

Review 6.  Current concepts in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia.

Authors:  Kathrin M Bernt; Stephen P Hunger
Journal:  Front Oncol       Date:  2014-03-25       Impact factor: 6.244

7.  Pax5 loss imposes a reversible differentiation block in B-progenitor acute lymphoblastic leukemia.

Authors:  Grace J Liu; Luisa Cimmino; Julian G Jude; Yifang Hu; Matthew T Witkowski; Mark D McKenzie; Mutlu Kartal-Kaess; Sarah A Best; Laura Tuohey; Yang Liao; Wei Shi; Charles G Mullighan; Michael A Farrar; Stephen L Nutt; Gordon K Smyth; Johannes Zuber; Ross A Dickins
Journal:  Genes Dev       Date:  2014-06-15       Impact factor: 11.361

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.